microRNA deregulation in keloids: an opportunity for clinical intervention?
- PMID: 26486103
- PMCID: PMC6496423
- DOI: 10.1111/cpr.12225
microRNA deregulation in keloids: an opportunity for clinical intervention?
Abstract
Keloids are defined as benign dermal scars invading adjacent healthy tissue, characterized by aberrant fibroblast dynamics and overproduction of extracellular matrix. However, the aetiology and molecular mechanism of keloid production remain poorly understood. Recent discoveries have shed new light on the involvement of a class of non-coding RNAs known as microRNAs (miRNA), in keloid formation. A number of miRNAs have differential expression in keloid tissues and keloid-derived fibroblasts. These miRNAs have been characterized as novel regulators of cellular processes pertinent to wound healing, including extracellular matrix deposition and fibroblast proliferation. Delineating the functional significance of miRNA deregulation may help us better understand pathogenesis of keloids, and promote development of miRNA-directed therapeutics against this condition.
© 2015 John Wiley & Sons Ltd.
Similar articles
-
LINC00937 suppresses keloid fibroblast proliferation and extracellular matrix deposition by targeting the miR-28-5p/MC1R axis.Histol Histopathol. 2021 Sep;36(9):995-1005. doi: 10.14670/HH-18-372. Epub 2021 Aug 23. Histol Histopathol. 2021. PMID: 34486677
-
Integrated Interaction Network of MicroRNA Target Genes in Keloid Scarring.Mol Diagn Ther. 2019 Feb;23(1):53-63. doi: 10.1007/s40291-018-0378-0. Mol Diagn Ther. 2019. PMID: 30604399
-
Comparative study of microRNA profiling in keloid fibroblast and annotation of differential expressed microRNAs.Acta Biochim Biophys Sin (Shanghai). 2013 Aug;45(8):692-9. doi: 10.1093/abbs/gmt057. Epub 2013 May 24. Acta Biochim Biophys Sin (Shanghai). 2013. PMID: 23709205
-
Molecular dissection of abnormal wound healing processes resulting in keloid disease.Wound Repair Regen. 2010 Mar-Apr;18(2):139-53. doi: 10.1111/j.1524-475X.2009.00553.x. Epub 2009 Dec 11. Wound Repair Regen. 2010. PMID: 20002895 Review.
-
Keloids: current concepts of pathogenesis (review).Int J Mol Med. 2009 Sep;24(3):283-93. doi: 10.3892/ijmm_00000231. Int J Mol Med. 2009. PMID: 19639219 Review.
Cited by
-
miR-320 inhibited ovarian cancer oncogenicity via targeting TWIST1 expression.Am J Transl Res. 2017 Aug 15;9(8):3705-3713. eCollection 2017. Am J Transl Res. 2017. PMID: 28861161 Free PMC article.
-
LINC00937 suppresses keloid fibroblast proliferation and extracellular matrix deposition by targeting the miR-28-5p/MC1R axis.Histol Histopathol. 2021 Sep;36(9):995-1005. doi: 10.14670/HH-18-372. Epub 2021 Aug 23. Histol Histopathol. 2021. PMID: 34486677
-
Roles of MMP-2 and MMP-9 and their associated molecules in the pathogenesis of keloids: a comprehensive review.Front Pharmacol. 2024 Nov 25;15:1444653. doi: 10.3389/fphar.2024.1444653. eCollection 2024. Front Pharmacol. 2024. PMID: 39654616 Free PMC article. Review.
-
Epigenetic Dysregulation in Autoimmune and Inflammatory Skin Diseases.Clin Rev Allergy Immunol. 2022 Dec;63(3):447-471. doi: 10.1007/s12016-022-08956-8. Epub 2022 Nov 8. Clin Rev Allergy Immunol. 2022. PMID: 36346551 Review.
-
Noncoding RNAs in Wound Healing: A New and Vast Frontier.Adv Wound Care (New Rochelle). 2018 Jan 1;7(1):19-27. doi: 10.1089/wound.2017.0765. Adv Wound Care (New Rochelle). 2018. PMID: 29344431 Free PMC article. Review.
References
-
- Careta MF, Fortes AC, Messina MC, Maruta CW (2013) Combined treatment of earlobe keloids with shaving, cryosurgery, and intralesional steroid injection: a 1‐year follow‐up. Dermatol. Surg. 39, 734–738. - PubMed
-
- Love PB, Kundu RV (2013) Keloids: an update on medical and surgical treatments. J. Drugs Dermatol. 12, 403–409. - PubMed
-
- Suarez E, Syed F, Alonso‐Rasgado T, Mandal P, Bayat A (2013) Up‐regulation of tension‐related proteins in keloids: knockdown of Hsp27, alpha2beta1‐integrin, and PAI‐2 shows convincing reduction of extracellular matrix production. Plast. Reconstr. Surg. 131, 158e–173e. - PubMed
-
- Cho JW, Il KJ, Lee KS (2013) Downregulation of type I collagen expression in silibinin‐treated human skin fibroblasts by blocking the activation of Smad2/3‐dependent signaling pathways: potential therapeutic use in the chemoprevention of keloids. Int. J. Mol. Med. 31, 1148–1152. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources